dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Lung Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (95.24) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahadue, FL; Soll, R | 1 |
| Costard-Jäckle, A; Cremer, J; Harringer, W; Haverich, A; Hirt, SW; Strüber, M | 1 |
| Fawcett, TA; Fracica, PJ; Huang, YC; Menache, MG; Moon, RE; Piantadosi, CA; Sane, AC; Simonson, SG; Young, SL | 1 |
| Crapo, JD; Duhaylongsod, FG; Fracica, PJ; Huang, YC; Piantadosi, CA; Welty-Wolf, KE; Young, SL | 1 |
| David-Cu, R; Findlay, RD; Taeusch, HW; Walther, FJ | 1 |
| Easa, D; Long, W; Mullett, M; Schumacher, R; Sundell, H; Walther, FJ | 1 |
| Cotton, R; Guthrie, R; Hirata, T; LeBlanc, M; Long, W; Mammel, M; Sell, M | 1 |
| Beaumont, E; Cook, L; Dhanireddy, R; Gerdes, J; Gerdes, M; Jarret, R; Kopleman, A; Long, W | 1 |
| Anday, E; Boros, S; Bucciarelli, R; Burchfield, D; Gong, A; Long, W; Zucker, J | 1 |
| Bard, H; Derleth, D; Long, W; Pauly, T; Robertson, C; Sauve, R; Stevenson, D; Vincer, M | 1 |
| Bard, H; Chernick, V; Finer, N; Krzeski, R; Long, W; McMillan, D; Schiff, D; Watts, J | 1 |
| Buck, R; Garland, J; Weinberg, M | 1 |
| Campbell, LA; Curstedt, T; Gunkel, JH; Long, WA; Merritt, TA; Robertson, B; Sherman, MP | 1 |
| al-Hifzi, I; Khan, M; Majeed-Saidan, MA | 1 |
| Rogers, D | 1 |
| Abbasi, S; Bhutani, VK; Gerdes, JS | 1 |
| Balaraman, V; Easa, D; Egan, E; Killeen, J; Ku, TL; Meister, J; Sood, SL; Tam, E; Uyehara, CF | 1 |
| Bhatt-Mehta, V; Schumacher, RE | 1 |
| Derleth, D; Finer, N; Long, W; McMurray, B; Mullett, M; Peliowski, A; Sankaran, K; van Houten, J; Walker, D; Wold, D | 1 |
| Allen, A; Boros, S; Corbet, A; Edwards, K; Gerdes, J; Houle, L; Long, W; McMillan, D; Schiff, D; Vaughan, R | 1 |
1 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Lung Diseases
| Article | Year |
|---|---|
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Time Factors | 2012 |
10 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Lung Diseases
| Article | Year |
|---|---|
One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Hospitalization; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Hospitalization; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
Topics: Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Hospitalization; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
Topics: Air; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Topics: Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Treatment Outcome | 1993 |
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Topics: Biological Products; Chronic Disease; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk | 1996 |
Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Autopsy; Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhagic Disorders; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Retrospective Studies | 1992 |
10 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Lung Diseases
| Article | Year |
|---|---|
Nebulized synthetic surfactant in reperfusion injury after single lung transplantation.
Topics: Adult; Aerosols; Drug Combinations; Fatty Alcohols; Female; Humans; Lung Diseases; Lung Transplantation; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Reperfusion Injury | 1995 |
Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry.
Topics: Animals; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Fatty Alcohols; Hemodynamics; Lung Diseases; Male; Oxygen; Papio; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Proteolipids; Pulmonary Edema; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Respiratory Mechanics | 1995 |
Artificial surfactant attenuates hyperoxic lung injury in primates. II. Morphometric analysis.
Topics: Aerosols; Animals; Blood Gas Analysis; Cell Division; Drug Combinations; Endothelium; Fatty Alcohols; Hemodynamics; Lung; Lung Diseases; Male; Microscopy, Electron; Oxygen; Papio; Phosphorylcholine; Polyethylene Glycols; Pulmonary Alveoli; Pulmonary Surfactants | 1995 |
Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants.
Topics: Animals; Biological Products; Drug Combinations; Epithelial Cells; Epithelium; Fatty Alcohols; Hemolysis; Hemorrhage; Humans; In Vitro Techniques; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Models, Biological; Phosphorylcholine; Polyethylene Glycols; Pulmonary Alveoli; Pulmonary Surfactants; Rats | 1995 |
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Topics: Cohort Studies; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemorrhage; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 1994 |
Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
Topics: Animals; Animals, Newborn; Biological Products; Cell Division; Drug Combinations; Fatty Alcohols; Lung Diseases; Macrophages, Alveolar; Models, Biological; Phagocytosis; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Rabbits; Streptococcal Infections; Streptococcus agalactiae | 1994 |
Pulmonary haemorrhage in low-birthweight babies.
Topics: Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Hyaline Membrane Disease; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants | 1993 |
Pulmonary haemorrhage, surfactant, and low-birthweight babies.
Topics: Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants | 1993 |
Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
Topics: Animals; Animals, Newborn; Bronchoalveolar Lavage; Disease Models, Animal; Drug Combinations; Fatty Alcohols; Intercellular Signaling Peptides and Proteins; Lung Diseases; Peptides; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome; Swine | 1998 |
Criteria for use of colfosceril (Exosurf) in neonates.
Topics: Apnea; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Infant, Newborn; Intubation, Intratracheal; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1992 |